Use of Mammary Lymphoscintigraphy and Intraoperative Radioguided Gamma Probe in Sentinel Lymph Node Biopsy of Breast Cancer.
- Author:
Soon KIM
;
Suk Gil JEON
;
Yoo Sa KIM
- Publication Type:Original Article
- Keywords:
Tc-99m antimony sulfide colloid;
Lymphoscintigraphy;
Intraoperative radioguided gamma probe;
Sentinel lymph node;
Breast cancer
- MeSH:
Antimony;
Biopsy;
Breast Neoplasms*;
Breast*;
Colloids;
Humans;
Lymph Node Excision;
Lymph Nodes;
Lymphatic Vessels;
Lymphoscintigraphy*;
Neoplasm Metastasis;
Sentinel Lymph Node Biopsy*
- From:Korean Journal of Nuclear Medicine
2000;34(6):478-486
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The sentinel lymph node is defined as the first draining node from a primary tumor and reflects the histologic feature of the remainder of the lymphatic basin status. The aim of this study was to evaluate the usefulness of lymphoscintigraphy and intraoperative radioguided gamma probe for identification and removal of sentinel lymph node in breast cancer. MATERIALS AND METHODS: Lymphoscintigraphy was performed preoperatively in 15 patients with biopsy proven primary breast cancer. Tc-99m antimony sulfide colloid was injected intradermally at four points around the tumor. Imaging acquisition included dynamic imaging, followed by early and late static images at 2 hours. The sentinel lymph node criteria on lymphoscintigraphy is the first node of the highest uptake in early and late static images. We tagged the node emitting the highest activity both in vivo and ex vivo. Histologic study for sentinel and axillary lymph node investigation was done by Hematoxylin-Eosin staining. RESULTS: On lymphoscintigraphy, three of 15 patients had clear lymphatic vessels in dynamic images, and 11 of 15 patients showed sentinel lymph node in early static image and three in late static 2 hours image. Mean detection time of sentinel lymph node on lymphoscintigraphy was 33.5+/-48.4 minutes. The sentinel lymph node localization and removal by lymphoscintigraphy and intraoperative gamma probe were successful in 14 of 15 patients (detection rate: 93.3%). On lymphoscintigraphy, 14 of 15 patients showed 2.47+/-2.00 sentinel lymph nodes. On intraoperative gamma probe, 2.36+/-1.96 sentinel lymph nodes were detected. In 7 patients with positive results of sentinel lymph node metastasis, 5 patients showed positive results of axillary lymph node (sensitivity: 72%) but two did not. In 7 patients with negative results of sentinel lymph node metastasis, all axillary nodes were free of disease (specificity: 100%). CONCLUSION: Sentinel lymph node biopsy with lymphoscintigraphy and intraoperative gamma probe is a reliable method to predict axillary lymph node metastasis in breast cancer, and unnecessary axillary lymph node dissection can be avoided.
